An observational study in Multiple Sclerosis, sponsored by Cairo University. Completed. Per ClinicalTrials.gov, last updated 2016-11-22.
Sponsored by Cairo University · Observational
The primary study aim is to depict the demographics, clinical and para clinical features of patients attending five tertiary referral multiple sclerosis (MS) centers in Egypt.
This requires effective and unified pooled registries to extract data from with a standardized, sufficient and high quality clinical, magnetic resonance imaging (MRI) data, neurophysiological data and body fluids.
Investigators want to shed light on the challenges that face both physicians and patients in the area of "diagnosis and treatment"
3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.
This study's enrollment of 2,752 is above the median of 100 across 1,016 observational studies indexed under Multiple Sclerosis.
Browse Multiple Sclerosis studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Radiologically isolated syndrome, Clinically isolated Syndrome , Multiple Sclerosis, Neuromyelitis optica spectrum disorders (NMOSD), MS mimics
Exclusion Criteria:
portrayed phenotypes and para-clinical data of Egyptian Multiple Sclerosis Patients
Time frame: 6 months
No study locations are listed for this record.
This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University